NCT02746185 Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban Status COMPLETED Phase PHASE3
NCT02746081 Phase I Study of BAY1436032 in IDH1-mutant Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02742623 A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer Status COMPLETED Phase N/A
NCT02728856 Evaluation of the Irritation Potential of Products in Human Eyes. Status COMPLETED Phase NA
NCT02728050 Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Status COMPLETED Phase PHASE1/PHASE2
NCT02714166 Evaluation of the Irritation Potential of Products in Human Eyes Status COMPLETED Phase NA
NCT02712008 Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema Status COMPLETED Phase PHASE2
NCT02710708 YAZ Post Authorization Safety Study (PASS)/Post Authorization Efficacy Study (PAES) in China Status COMPLETED Phase PHASE4
NCT02702908 Second Primary Cancers in Patients With Castration Resistant Prostate Cancer Status COMPLETED Phase N/A
NCT02696642 Phase I Study of Anetumab Ravtansine in Hepatic or Renal Impairment Status COMPLETED Phase PHASE1
NCT02695810 The PRE-D Trial: Effect of Dapagliflozin, Metformin and Physical Activity in Pre-diabetes Status COMPLETED Phase PHASE2